Myriad Genetics (MYGN) Enterprise Value (2009 - 2026)
Myriad Genetics (MYGN) reported Enterprise Value of -$124.4 million for Q1 2026, down 35.51% year-over-year from -$192.9 million in Q1 2025, and up 16.84% quarter-over-quarter from -$149.6 million in Q4 2025.
Myriad Genetics (MYGN) Enterprise Value (2009 - 2026) Analysis & Trends
Myriad Genetics (MYGN) has 18 years of Enterprise Value data on file, last reported at -$124.4 million in Q1 2026.
- Enterprise Value for Q1 2026 came in at -$124.4 million, down 35.51% year-over-year; the trailing twelve-month figure through Mar 2026 was -$124.4 million (down 35.51% YoY), and the FY2025 annual result was -$149.6 million, down 46.09% from the prior year.
- Enterprise Value climbed to -$124.4 million in Q1 2026 per MYGN's latest filing, from -$149.6 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$74.4 million in Q2 2025 and troughed at -$267.4 million in Q1 2022.
- A 5-year average of -$129.1 million and a median of -$114.9 million in 2022 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2022 and 2023: Enterprise Value sank 51.85% in 2022, then soared 70.57% in 2023.
- A 5-year view of Enterprise Value shows it stood at -$114.9 million in 2022, then dropped by 22.63% to -$140.9 million in 2023, then climbed by 27.32% to -$102.4 million in 2024, then sank by 46.09% to -$149.6 million in 2025, then rose by 16.84% to -$124.4 million in 2026.
- Business Quant data shows MYGN's Enterprise Value at -$124.4 million in Q1 2026, -$149.6 million in Q4 2025, and -$145.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | -462.00 Mn |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | -3.25 Bn |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | -5.69 Bn |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | -200.53 Mn |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | -1.81 Bn |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | -1.98 Bn |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | -1.10 Bn |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | -1.16 Bn |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | -60.60 Mn |
| 10 | Myriad Genetics | 411.34 Mn | 286.94 Mn | 137.60 Mn | -124.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -124.40 Mn |
| Dec 31, 2025 | -149.60 Mn |
| Sep 30, 2025 | -145.40 Mn |
| Jun 30, 2025 | -74.40 Mn |
| Mar 31, 2025 | -91.80 Mn |
| Dec 31, 2024 | -102.40 Mn |
| Sep 30, 2024 | -99.90 Mn |
| Jun 30, 2024 | -97.30 Mn |
| Mar 31, 2024 | -104.30 Mn |
| Dec 31, 2023 | -140.90 Mn |
| Sep 30, 2023 | -86.30 Mn |
| Jun 30, 2023 | -121.60 Mn |
| Mar 31, 2023 | -78.70 Mn |
| Dec 31, 2022 | -114.90 Mn |
| Sep 30, 2022 | -191.20 Mn |
| Jun 30, 2022 | -204.10 Mn |
| Mar 31, 2022 | -267.40 Mn |
| Dec 31, 2021 | -338.80 Mn |
| Sep 30, 2021 | -366.20 Mn |
| Jun 30, 2021 | -164.50 Mn |